BioVersys AG

10 articles with BioVersys AG

• OpGen Subsidiary Curetis and BioVersys Sign Collaboration Agreement for Clinical Trial Support

  10/25/2022

  OpGen, Inc. and BioVersys AG today announced the signing of a collaboration agreement for the deployment and use of the Unyvero platform in BioVersys’ upcoming Phase II clinical trial of novel drug candidate BV100.

• 

  Global Roundup: BioVersys Secures CARB-X Funds for Multidrug Resistant Research

  6/3/2021

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
• 

  BioSpace Global Roundup: Boehringer Ingelheim Launches Weight-Loss Trials for NASH

  4/15/2021

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
• 

  Global Roundup: Two Big Deals Highlighting Biopharma Growth in China and More

  11/19/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
• 

  BioSpace Global Roundup, Sept. 3

  9/3/2020

  Biopharma and life science companies from across the globe provide updates on their pipelines and businesses.
• 

  BioSpace Global Roundup, Oct. 31

  10/31/2019

  Companies from across the globe share updates to their businesses and pipelines.

• BioVersys Receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies

  10/29/2019

  BioVersys AG announced, US$ 3.94 million in non-dilutive funding from CARB-X, with the possibility of US$ 4.98 million more if certain project milestones are met.

• BioVersys AG And Aptuit LLC Announce Collaboration To Identify Novel Approaches To Treat Serious Infections From Gram-Negative Pathogens

  3/7/2017

• BioVersys AG And Enamine Ltd. Announce Extension Of Drug Discovery Collaboration To Address Multidrug-Resistant Bacterial Infections

  12/2/2014

• BioVersys AG And SARomics Biostructures Join Efforts To Combat Multidrug-Resistant Bacterial Infections

  2/5/2014